Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 3, Pages 453
Publisher
MDPI AG
Online
2021-03-15
DOI
10.3390/antiox10030453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration
- (2020) Jingyi He et al. Oxidative Medicine and Cellular Longevity
- Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease
- (2020) Maho Kubota et al. PLoS One
- Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson’s model
- (2020) Priyadarshika Pradhan et al. Cell Death & Disease
- Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
- (2020) Gillian D. Mahumane et al. Pharmaceutics
- Monitoring the Redox Status in Multiple Sclerosis
- (2020) Masaru Tanaka et al. Biomedicines
- Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability
- (2020) Anis Syauqina Mohd Zaffarin et al. International Journal of Nanomedicine
- Evaluating Dose- and Time-Dependent Effects of Vitamin C Treatment on a Parkinson’s Disease Fly Model
- (2019) Huynh Man Anh et al. Parkinsons Disease
- Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease
- (2019) Mei-Ling Bermúdez et al. NEUROSCIENCE
- N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
- (2019) Daniel A. Monti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial
- (2019) Michael A. Schwarzschild et al. NEUROLOGY
- Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
- (2019) Yingyan Wu et al. NEUROLOGICAL SCIENCES
- Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications
- (2019) Ibrahim Khalil et al. Antioxidants
- The antioxidant status of coenzyme Q10 and vitamin E in children with type 1 diabetes
- (2018) Usama M. Alkholy et al. Jornal de Pediatria
- Bioavailability of coenzyme Q 10 supplements depends on carrier lipids and solubilization
- (2018) Guillermo López-Lluch et al. NUTRITION
- Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy
- (2018) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress
- (2017) Lisa D. Coles et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
- (2017) Laurie K. Mischley et al. Journal of Parkinsons Disease
- Trends in the Incidence of Parkinson Disease in the General Population
- (2016) Sirwan K. L. Darweesh et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Coenzyme Q10 for Patients with Parkinson';s Disease: A Systematic Review and Meta-Analysis
- (2016) Ahmed Negida et al. CNS & Neurological Disorders-Drug Targets
- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease
- (2016) Shamik Bhattacharyya et al. MOVEMENT DISORDERS
- Intake of antioxidant vitamins and risk of Parkinson's disease
- (2016) Katherine C. Hughes et al. MOVEMENT DISORDERS
- N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
- (2016) Daniel A. Monti et al. PLoS One
- Distribution of vitamin C is tissue specific with early saturation of the brain and adrenal glands following differential oral dose regimens in guinea pigs
- (2015) Stine Hasselholt et al. BRITISH JOURNAL OF NUTRITION
- A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease
- (2015) Laurie K. Mischley et al. MOVEMENT DISORDERS
- Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease
- (2015) Kazuki Ide et al. NUTRITION
- Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease
- (2015) Maya Katz et al. PARKINSONISM & RELATED DISORDERS
- Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease
- (2015) Asako Yoritaka et al. PARKINSONISM & RELATED DISORDERS
- Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain
- (2015) Rodrigo Figueroa-Méndez et al. Frontiers in Physiology
- Randomized controlled trial of oral glutathione supplementation on body stores of glutathione
- (2014) John P. Richie et al. EUROPEAN JOURNAL OF NUTRITION
- Diagnostic accuracy of parkinsonism syndromes by general neurologists
- (2014) Juho Joutsa et al. PARKINSONISM & RELATED DISORDERS
- Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
- (2014) Ning Zhang et al. PLoS One
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- The chemistry and biological activities of N-acetylcysteine
- (2013) Yuval Samuni et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
- (2013) Huajun Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
- (2013) Mary J. Holmay et al. CLINICAL NEUROPHARMACOLOGY
- Bioavailability of vitamin E in humans: an update
- (2013) Patrick Borel et al. NUTRITION REVIEWS
- Physiology and Pathophysiology of Carnosine
- (2013) Alexander A. Boldyrev et al. PHYSIOLOGICAL REVIEWS
- The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease
- (2012) María E. Solesio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Authors' Perspective: What is the Optimum Intake of Vitamin C in Humans?
- (2012) Balz Frei et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Safety Survey of Intranasal Glutathione
- (2012) Laurie K. Mischley et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases
- (2012) Mahesh Ramalingam et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway
- (2012) Li Gong et al. JOURNAL OF NEUROCHEMISTRY
- Coenzyme Q10 deficiency in patients with Parkinson's disease
- (2012) Laurie K. Mischley et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease
- (2012) Sara Cipriani et al. PLoS One
- Lipid peroxidation and neurodegenerative disease
- (2011) Tanea T. Reed FREE RADICAL BIOLOGY AND MEDICINE
- Effects of Oral Glutathione Supplementation on Systemic Oxidative Stress Biomarkers in Human Volunteers
- (2011) Jason Allen et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action
- (2011) Ting-Ge Zhu et al. NEUROSCIENCE LETTERS
- Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
- (2010) Anamitra Ghosh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial medicine for neurodegenerative diseases
- (2010) Heng Du et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- An Update on Vitamin E, Tocopherol and Tocotrienol—Perspectives
- (2010) Maria Laura Colombo MOLECULES
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
- (2010) Joanne Clark et al. PLoS One
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization
- (2009) Serge Guerreiro et al. JOURNAL OF NEUROCHEMISTRY
- A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
- (2009) Connie Marras et al. MOVEMENT DISORDERS
- Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease
- (2009) Robert A. Hauser et al. MOVEMENT DISORDERS
- Ascorbic Acid Increases the Number of Dopamine Neurons In Vitro and in Transplants to the 6-OHDA-Lesioned Rat Brain
- (2008) V. Bagga et al. CELL TRANSPLANTATION
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The coenzyme Q10 status of the brain regions of Parkinson’s disease patients
- (2008) Iain P. Hargreaves et al. NEUROSCIENCE LETTERS
- Carnisone Increases Efficiency of DOPA Therapy of Parkinson's Disease: A Pilot Study
- (2008) Alexander Boldyrev et al. REJUVENATION RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started